ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Cardiac

May 27, 2017
A statewide quality initiative database that included over 11,500 pts undergoing surgical AVR (SAVR) who were assessed for outcomes based on pre-TAVR and post-TAVR time periods (divided into early TAVR and commercial TAVR).  SAVR rates increased with each time period, wheres predicted mortality rates decreased, observed mortality was lowest during th
May 27, 2017
Data from the Centers for Medicare and Medicaid Services related to patients aged 65 and older who underwent TAVR during a 2 year period were evaluated, stratified into older (age 90 or greater; 19.3%) and younger cohorts.  Nonagenarians had fewer comorbidities.  Mortality was higher in nonagenarians (8.4% vs 5.9%) as was morbidity (25.4% vs 21.5%). 
May 25, 2017
This video shows the treatment of a 5-year-old patient with a rapidly enlarging aneurysm and left ventricular outflow tract to pulmonary artery shunt.
May 24, 2017
Manuel Castella of Cirugia Cardiovascular Hospital Clínic, University of Barcelona, Spain, discusses different strategies to achieve a satisfactory outcome in atrial fibrillation surgery.
May 23, 2017
In this video, the sixth in a seven-part series, Tristan Yan completes the “French Cuff” annular anastomosis, and demonstrates the coronary button reimplantation technique via a mini-sternotomy incision.
May 23, 2017
The authors conducted a retrospective cohort study of 88 patients that received methylene blue (MB) for refractory vasoplegia following cardiopulmonary bypass.  Administration of MB was associated with an 8 mmHg increase in mean arterial pressure, with the peak response occurring at 2 hours after completion of dose.  
May 22, 2017
The purpose of this study was to evaluate differences in long-term survival without the influence of early mortality, and to identify factors associated with one-year conditional ten-year survival after heart transplantation across different age and diagnostic groups using the UNOS database.
May 22, 2017
A surprisingly readable Australasian manuscript on risk prediction models for cardiac surgery. Interesting that the class of dyspnoea was not captured in 5.28% of the operated patients.
May 18, 2017
Following a charitable initiative launched in 2014 to impact one million underserved people by 2020, Edwards provides a current update on progress toward that goal.   Dr.
May 17, 2017
Using data from the CoreValve US Expanding Use Study, outcomes for patients with end stage renal disease (ESRD) undergoing TAVR were evaluated using an endpoint of all-cause mortality or major stoke at 1 year.  Mortality at 1 year was 30%, and the stroke incidence was 2.1%.  New permanent pacemaker need was 27%.

Pages